Prostate cancer Board decisions

The Veteran's claims for service connection for diabetes mellitus, type II (DM II) and prostate cancer are remanded due to insufficient information regarding his exposure to herbicide agents during active duty in the Republic of Korea.

The Board has remanded the claims for service connection due to insufficient opinions regarding the Veteran's exposure to commercial herbicides at Fort Dix, which is required by the PACT Act.

The Board denied the Veteran's claim for an initial compensable disability rating for post-operative residuals of prostate cancer, finding that there is no evidence to support a finding of voiding dysfunction or renal dysfunction due to his service-connected condition.

The Board has remanded the claims for service connection for coronary artery disease and prostate cancer, both linked to herbicide agent exposure. Additional development is needed to obtain all relevant VA treatment records.

The Veteran's prostate cancer is granted as presumptively related to herbicide agent exposure during service in Vietnam.

The Board denied service connection for coronary artery disease (CAD), prostate cancer, and diabetes mellitus, type II, as there was no evidence of herbicide exposure in service or any other basis for service connection.

The Board has remanded the cases for additional examinations and to obtain outstanding VA treatment records. The appellant's PTSD and prostate cancer residuals are rated at 70 percent and 40 percent, respectively.

The Veteran's service connection claims for congestive heart failure, aortic aneurysm with dissection, prostate cancer, and erectile dysfunction secondary to prostate cancer are being remanded due to the need for additional development related to toxic exposure during service. The PACT Act requires VA to obtain medical opinions regarding potential links between these disabilities and in-service exposures.

The Veteran's claim for a total disability rating based upon individual unemployability (TDIU) due to service-connected disabilities prior to September 23, 2019 is denied as the evidence does not demonstrate he was unemployed or marginally employed due to his service-connected disabilities.

The Veteran's initial claim for service connection for penile and urethral cancer was granted, with a 100 percent rating effective June 7, 2018. The rating was increased to 40 percent from May 6, 2022 to July 1, 2022, and to 100 percent for metastatic lung cancer starting July 1, 2022. He also received a separate 30 percent rating for erectile dysfunction with loss of use of a creative organ.

Your proposed decrease in the disability rating for prostate cancer from 60 percent to 40 percent was not reduced, so your appeal is dismissed.

The Veteran's claim for an earlier effective date for additional dependency compensation for his spouse was denied because he did not submit the required application form within one year of notifying VA of his dependent spouse's existence.

The Board has decided to remand the claims for prostate cancer, diabetes mellitus, and skin condition due to the need for VA medical opinions regarding their etiology.

The Board denied service connection for prostate cancer, hypertension, and diabetes mellitus type II as there was no evidence of exposure to herbicide agents during service or a causal link between the conditions and service.

The Veteran's prostate cancer is granted service connection due to exposure to herbicide agents in Thailand. The left knee disability issue requires further examination as the relationship to his right knee disability and other conditions is unclear.

The Veteran's appeals for service connection for various conditions have been dismissed due to withdrawal of the claims.,Service connection has not been established for gastroesophageal reflux disease (GERD).

The Board has remanded the Veteran's claims for lung cancer, prostate cancer, and hepatic steatosis due to potential exposure to contaminated water at Camp Lejeune. The case is also related to the PACT Act.

The Veteran's claim for an effective date prior to April 19, 2016, for the award of service connection for prostate cancer was denied because there is no evidence that he filed a formal or informal claim for this condition before April 19, 2016. The earliest diagnosis of prostate cancer was on April 14, 2016.

The Veteran's prostate cancer is presumed to be due to herbicide exposure during service. His acquired psychiatric disorder, specifically depression, is found to be secondary to his service-connected prostate cancer.

The Board has granted an effective date of December 6, 2023 for the award of service connection for prostate cancer due to herbicide exposure in Thailand under the PACT Act. The Veteran's claim was initially denied in July 2019 and then vacated by the CAVC before being granted again in April 2023.